Montecito Medical Acquires Surgery Center Property in North Texas

NASHVILLE, Tenn.–(BUSINESS WIRE)–Montecito Medical, the nation’s leading privately held buyer of medical office properties, has acquired a 14,600-square-foot surgery center building in Granbury, TX. The ambulatory surgery center (ASC) property is 100% leased to Baylor Scott & White Surgicare at Granbury. “We are pleased to acquire yet another great medical real estate asset in the … [Read more…]

United Health Foundation Awards $2 Million Grant to Rainbow Health To Increase Access to Mental Health Care for LGBTQ+ and BIPOC Youth

Three-year commitment supports behavioral health and well-being of LGBTQ+ and BIPOC youth in the Twin Cities MINNETONKA, Minn.–(BUSINESS WIRE)–The United Health Foundation, the philanthropic foundation of UnitedHealth Group (NYSE: UNH), today announced a three-year, $2 million grant partnership to address disparities related to suicide, depression and anxiety among LGBTQ+ and BIPOC youth and young adults … [Read more…]

Internship Program Empowers Canada’s Next Generation of Bio-Economy Workers

OTTAWA, Ontario–(BUSINESS WIRE)–#HR–BioTalent Canada celebrates the National Day of Work-Integrated Learning (WIL), today, by releasing the impacts of their student work experiences – through the Student Work Placement Program (SWPP). The Program continues to empower the next generation of bio-economy workers. Since 2017, BioTalent Canada’s project under the SWPP has successfully placed more than 11,000 … [Read more…]

Poxel will Report its 2022 Full Year Results on March 23, 2023

LYON, France–(BUSINESS WIRE)–Regulatory News: POXEL SA (Euronext: POXEL – FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced it will report its 2022 Full year results on March 23, 2023, before market opening. The management team will … [Read more…]

Incyte Announces FDA Approval of Zynyz™ (retifanlimab-dlwr) for the Treatment of Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC)

— First regulatory approval for Incyte PD-1 inhibitor based on the results of the POD1UM-201 trial — Zynyz is also being studied in additional tumor types and in combination with other Incyte pipeline compounds WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz™ (retifanlimab-dlwr), a humanized monoclonal … [Read more…]

BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases

OTTAWA, Ontario–(BUSINESS WIRE)–BIOTECanada welcomes the government’s dedicated investment of $1.5 B over 3 years to advance effective access to medicines, improve evidence and decisions for the care of patients with rare diseases. The integrated approach, bringing federal, provincial and territorial governments together with national clinical practice expertise networks including clinicians, researchers and industry will be … [Read more…]

Mental Health Leader SonderMind to Provide More Personalized Care with Acquisition of Mindstrong Technology

Provider of high-quality mental health care adds capabilities to deliver more personalized care journeys and enhance clinicians’ experience DENVER–(BUSINESS WIRE)–#mentalhealth–Today, leading mental health care provider SonderMind announced the acquisition of Mindstrong’s technology and transition of select technology team members, accelerating SonderMind’s efforts to revolutionize the industry by delivering personalized, objectively measurable, high-quality care. “Technology has … [Read more…]

Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities

– Funding Will Reach Under-Resourced Communities Impacted by the HIV Epidemic as Part of Gilead’s Zeroing In™: Ending the HIV Epidemic Grant Program – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $3 million in grant funding to eight organizations to provide services to communities disproportionately impacted … [Read more…]

Particle Health to Showcase Industry-Leading Data Interoperability for Individual Access at ViVE 2023

Particle Index to enable event attendees to securely obtain their health records onsite. The company will also debut the Particle FOCUS solution suite designed to automatically refine patient data into code-based sets beyond C-CDA or FHIR structures NEW YORK–(BUSINESS WIRE)–Particle Health, an interoperability platform that aggregates and delivers actionable patient data and insights to healthcare … [Read more…]

Report: More Physicians Are Taking Short-Term Locum Tenens Assignments

CHG Healthcare’s State of Locum Tenens Report Outlines Shifts Within the Temporary Staffing Sector for Physicians and Healthcare Organizations SALT LAKE CITY–(BUSINESS WIRE)–CHG Healthcare, the nation’s largest provider of locum tenens services, today released its 2023 State of Locum Tenens Report, an overview of trends in today’s short-term physician staffing landscape. Highlighting key industry insights, … [Read more…]